<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Development or progression of ophthalmopathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Development or progression of ophthalmopathy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Development or progression of ophthalmopathy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Four hundred forty-three patients with Graves' hyperthyroidism were randomly assigned to receive radioiodine, radioiodine followed by a three-month course of prednisone, or methimazole for 18 months. Development or worsening of ophthalmopathy occurred more often in the radioiodine than in the methimazole group. Worsening of ophthalmopathy was prevented by the administration of prednisone.</div><div class="graphic_reference">Data from: Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338:73.</div><div id="graphicVersion">Graphic 52658 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
